tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Spiritus Mundi PLC Amends Acquisition Terms for Clinical Diagnostics Targets

Story Highlights
Spiritus Mundi PLC Amends Acquisition Terms for Clinical Diagnostics Targets

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest update is out from Spiritus Mundi PLC ( (GB:SPMU) ).

Spiritus Mundi PLC has amended its acquisition terms to directly acquire Restalyst Pte. Ltd. and Reste Laboratories Pte. Ltd., bypassing a previously planned corporate reorganization. The company is raising additional funds to complete this acquisition and publish its 2024 Annual Report. If the acquisition fails, trading of the company’s shares, currently suspended, is expected to resume. The acquisition is considered a Material Related Party Transaction due to Zaccheus Peh’s involvement, who is a director and significant shareholder in the target companies.

More about Spiritus Mundi PLC

Spiritus Mundi PLC is a Special Purpose Acquisition Company (SPAC) focused on acquiring targets in the clinical diagnostics sector across Europe and Asia.

Technical Sentiment Signal: Buy

For an in-depth examination of SPMU stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1